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The cutis laxa syndromes are multisystem disorders that share loose redundant
inelastic and wrinkled skin as a common hallmark clinical feature. The underlying
molecular defects are heterogeneous and13different geneshavebeen involveduntil
now, all of thembeing implicated in elastic fiber assembly.Weprovide heremolecular
and clinical characterization of three unrelated patients with a very rare phenotype
associating cutis laxa, facial dysmorphism, severe growth retardation, hyperostotic
skeletal dysplasia, and intellectual disability. This disorder called Lenz–Majewski
syndrome (LMS) is associatedwith gain of functionmutations inPTDSS1, encoding an
enzyme involved in phospholipid biosynthesis. This report illustrates that LMS is an
unequivocal cutis laxa syndrome and expands the clinical and molecular spectrum of
this group of disorders. In the neonatal period, brachydactyly and facial dysmorphism
are two early distinctive signs, later followed by intellectual disability and
hyperostotic skeletal dysplasia with severe dwarfism allowing differentiation of
this condition from other cutis laxa phenotypes. Further studies are needed to
understand the link between PTDSS1 and extra cellular matrix assembly.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
© 2018 The Authors. American Journal of Medical Genetics Part A Published by Wiley Periodicals, Inc.
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1 | INTRODUCTION
Congenital cutis laxa (CL) is a rare and heterogeneous condition
characterized byover-folded skin giving a prematurely aged appearance
from birth onwards. Based on its accompanying features, it usually falls
within a clinical spectrum that to date includes thirteen delineated
conditions corresponding to FBLN5-, FBLN4-, ELN-, ATP6V0A2-, PYCR1-
, ALDH18A1-, RIN2-, LTBP4-, ATP6V1E1-, and ATP6V1A-related cutis
laxa, gerodermia osteodysplastica, occipital horn syndrome, and arterial
tortuosity syndrome (OMIM 219100, 614437, 130160, 219200,
614438, 219150, 610222, 613177, 108746, 607027, 231070,
304150, 208050) (Callewaert & Urban, 2016; Loeys, De Paepe, &
Urban, 2011; Vanakker, Callewaert, Malfait, & Coucke, 2015; Van
Damme et al., 2017; Van Maldergem, Dobyns, & Kornak, 2009; Van
Maldergem & Loeys, 2009). The underlying molecular defects in CL
perturbextracellularmatrix assemblyand/orhomeostasisand involveall
steps in elastic fiber formation. An activation of TGFβ signaling, which
plays a crucial role in soft connective tissue and skeletal development,
has been observed in several types of CL (MacFarlane, Haupt, Dietz, &
Shore, 2017; Renard et al., 2010).
We describe here three patients with Lenz–Majewski syndrome
(LMS;OMIM612792), which is a very rare hyperostotic skeletal dysplasia
with intellectual disability (Lenz&Majewski, 1974), belonging to the bona
fide congenital CL group of syndromes. LMS is caused by activating de
novo heterozygous mutations in PTDSS1, encoding phosphatidylserine
synthase 1 (PSS1). It is not understood at present why deregulated PSS1
activity in theendoplasmic reticulumcan result inskeletaldysplasiaandCL
(Sousaetal., 2014). Theskinabnormality isparticularly striking in the three
patients described here. One patient was initially referred to the Cutis
Laxa Study Group for advice and has been briefly reported in the seminal
paperdescribing themolecular basisof LMS (Sousaet al., 2014). Theother
twopatientsdescribed for the first timehere, are theeighthandninthLMS
patients reported with a defined PTDSS1 mutation.
2 | SUBJECTS
2.1 | Informed consent
Written informed consent was obtained from the guardians of all
patients.
2.2 | Patient 1
This girl was born at term after an uneventful pregnancy to parents aged
27 and 30 years, originating from Bohemia in the Czech Republic. Her
birth weight was 2700 g (−1.8 SD), length was 44 cm (−3.5 SD), and OFC
was 32 cm (−3SD). Over-folded skin affecting thewhole body, prominent
veins, joint laxity, brachydactyly, and lipodystrophy of buttocks were
present. A large fontanelle and a distinct facial dysmorphism including
broad forehead, telecanthus, wide mouth, long philtrum, and thin
vermilion of the lips were also observed (Figure 1). Her growth and
development were severely delayed. At 9 years, she could not walk
without assistance, her height was 84 cm (−9 SD), weight was 10.1 kg
(−8.7 SD), and OFC was 45.5 cm (−5 DS). She has no speech. Her skin
appeared thin, with wrinkles distributed regularly over her whole body.
Tooth eruption was delayed. Changes in her facial gestalt were obvious:
prognathism, prominent eyes, coarseness, and a progeroid appearance.
Sparse hair, oligodontia, and kyphoscoliosis were also noted. Over the
years, fading of her CL was seen. Brain MRI showed diffuse cortical
atrophy, enlarged lateral ventricles, and apparent pituitary hypoplasia.
Bone X-rays showed structural changes to all bones, with sclerosismainly
in the skull and vertebra, hip dislocation, turricephaly, mildly delayed
ossification and thickness of the long bone diaphyses.
2.3 | Patient 2
Patient2wasamalebornat41weeksofgestation,withabirthweight of
2310g (−2.2 SD), a length of 46 cm (−3 SD), and OFC of 32 cm (−3 SD).
Widespread thin skin wrinkles were present all over the body and the
skin was translucent. Facial dysmorphism comprising broad forehead,
prominent eyes, telecanthus, medial crease of the philtrum, thin
vermilion of the lips, and retrognathia was observed (Figure 2). His
developmental milestones were severely delayed: he walked without
assistance at 40 months and learned only a few words. Generalized
seizures without fever started at 4 years and were responsive to
antiepileptic drugs. Fontanelle closure was delayed until 9 years. When
examined in adulthood, a coarse long face, tall and broad chin with
marked prognathism, broad forehead, highly arched thick eyebrows,
telecanthus, high and broad nasal bridge, smooth philtrum and thin
vermilion of the lips were observed. Prominent veins and limited
extension of elbows were also noted (Figure 3) alongside with major
brachydactyly of fingersand toes, a sandal gap, deeppalmar creases, and
hands acrogeria with skinwrinkles on their dorsal aspects (Figure 4). His
progressive cranial bone deformity was associated with profound
deafness. At 26 years of age, OFC was 54 cm (−2 SD); height was
123.4 cm (− 8.6 SD) an weight 33.8 kg (−5 SD). On skeletal survey a
severe and generalized hyperostostic dysplasia was observed (Figure 5)
with thickening of cranial vault, marked sclerosis of the skull base and
facial bones, a disproportionately enlarged mandible, shortened broad
ribs, hyperostotic clavicles and scapulae, dense vertebral bodies,
hyperostotic iliac wings, and bilateral hip dislocation. Long bones
exhibited diaphyseal undermodeling, marked hyperostosis, and cortical
thickening. A severe shortening of the metacarpal bones especially
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those of the 4th and 5th fingers, a bilateral overdevelopment of the 1st
ray proximal phalanx and the fusion of proximal and intermediate
phalanges of 2nd to 5th ray was observed.
2.4 | Patient 3
Patient 3 was the second child of healthy non-consanguineous
Romanian parents aged 38 and 36 years. A nuchal edema prompted
prenatal cytogenetic analysis indicating a 46, XX fetal karyotype.
Delivery by caesarean section at 38 weeks of gestation gave birth to a
female baby with normal weight (2570 g; −1.4 SD) and length (51 cm;
+0.3 SD), and a small head size (31 cm; −2.5 SD). Skin wrinkles were
present all over her body and head, giving her a progeroid appearance
with sagging cheeks. A large anterior fontanelle and facial dysmorphism
including telecanthus, a long philtrumwith amedial crease, downturned
corners of the mouth, thin vermilion of the lips, and retrognathia were
observed (Figure 6). Moderate brachydactyly of all fingers was noted,
affecting particularly the 4th and 5th rays,with interdigitalwebbing, and
clinodactyly. A persistent foramen ovale was diagnosed on heart
ultrasound. At 3 months, a deceleration of head growth was noted with
anOFCat 34 cm (−5.9 SD) aswell as short fingers and symphalangismof
III, IV, and V digits. At the age of 17 months she showed a mild
developmental delay. After exclusion of a congenital cutis laxa gene
panel by NGS, LMS was considered based on the clinical presentation.
3 | RESULTS
Sequencing of PTDSS1 identified a heterozygous missense c.794T>C (p.
Leu265Pro) mutation in exon 7 in patient 1, a heterozygous missense
c.284G>T (p.Arg95Leu)mutation in exon3 in patient 2, and aheterozygous
missensemutation c.806C>T (p.Pro269Leu) in exon 7 in patient 3. None of
the variants were present in public (gnomAD, ExAC, ExomeVariant Server,
FIGURE 2 Patient 2: Cutis laxa (notably in the neck), lipodystrophy, prominent eyes, and thin vermilion of the lips are seen in the first year of life
FIGURE 1 Photographs of patient 1 at 6 months (left panel, middle panel, hand) and 18 months (upper right photograph) showing cutis
laxa, prominent veins, lipodystrophy (arrow), brachydactyly and facial dysmorphism. [Color figure can be viewed at wileyonlinelibrary.com]
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dbSNP) or in-house control databases. All three variants were predicted
damaging or equivalent by SIFT, PolyPhen, MutationTaster, Provean, and
other tools using the Variant Effect Predictor (http://www.ensembl.org/
info/docs/tools/vep/index.html). De novo inheritance was confirmed in
patient 3. In the two other cases, parental samples were not available.
4 | DISCUSSION
In the present report of three patients with congenital CL, we provide
evidence for a fourteenth etiology underlying this cutaneous
phenotype (Table 1). Gain of function mutations in PTDSS1 underlie
LMS, which is an extremely rare syndrome with only 16 sporadic cases
reported in the literature between 1969 and 2015 (Lenz & Majewski,
1974; Majewski, 2000; Sousa et al., 2014; Tamhankar et al., 2015;
Whyte et al., 2015). Clinical features of LMS include craniotubular
hyperostosis, loose skin, progeroid appearance, marked growth failure,
andmoderate to severe intellectual disability. Loose atrophic skin or CL
has been described in all reported patients.
Sousa et al. (2014) identified causative heterozygous missense de
novo mutations in PTDSS1 in five unrelated LMS-affected patients. The
c.1058A>G; (p.Gln353Arg) mutation in exon 9 was identified in three
previously describedpatientswhile twonewcases harbored c.794T>C; (p.
Leu265Pro) and c.805C>T; (p.Pro269Ser) mutations in exon 7. The p.
Leu265Promutation corresponds to patient 1 in this report, while patient
3 in this report has c.806C>T; (p.Pro269Leu) resulting in a different amino
acid substitution at the same Pro269 position to another LMS patient
FIGURE 4 Patient 2: Hands and feet showed short toes and fingers, sandal gaps, deep palmar creases, and hands acrogeria with skin
wrinkles. [Color figure can be viewed at wileyonlinelibrary.com]
FIGURE 3 Patient 2: At 25 years, note the tall and broad chin with marked prognathism, long face, broad forehead, high arched thick
eyebrows, high and broad nasal root, thin vermilion of the lips, limited extension of the elbow joints, strabismus, and prominent veins. [Color
figure can be viewed at wileyonlinelibrary.com]
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reported by Sousa et al. (2014). Since then, two further LMSpatients have
been described, with mutations in exon 7 (Tamhankar et al., 2015;
Whyte et al., 2015). This means that LMS is a very rare disease with our
description here of the novel c.284G>T; (p.Arg95Leu), and c.806C>T; (p.
Pro269Leu) PTDSS1 mutation representing only the eighth and ninth
patients with confirmedmolecular diagnoses reported so far. Many of the
reported mutations are recurrent at specific amino acid positions and all
cluster in non-transmembrane domains, which are found on the luminal
FIGURE 6 Patient 3 at birth. Prominent wrinkling of the skin in the neck, forehead, chin, and right thigh can be seen. The patient has a
long philtrum with a medial crease, thin vermilion of the lips, telecanthus, sagging cheeks, and retrognathia which are part of the distinctive
facial dysmorphism. Moderate brachydactyly of all fingers was noted, particularly affecting the 4th and 5th rays, also with interdigital webbing
and clinodactyly. [Color figure can be viewed at wileyonlinelibrary.com]
FIGURE 5 Skeletal survey of patient 2. The patient has generalized hyperostostic dysplasia, an enlarged mandible, shortened broad ribs,
bilateral hip dislocation, cortical thickening of the long bones, very short metacarpals and symphalangism by fusion of proximal and
intermediate phalanges of 2nd to 5th ray, similar to those observed in patient 3 (not shown)
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side of the endoplasmic reticulum/mitochondria-associated membranes.
They also locate at or nearby to amino acid residues in which mutations
were previously demonstrated to be activating in a study byOhsawa et al.
(2004) who studied PSS1 activity following systematic alaninemutagene-
sis inChineseHamsterovary (CHO)cells. Enzymatic studies inLMSpatient
fibroblasts confirmed similar findings, demonstrating increased synthesis
of PS associated with resistance to PS feedback inhibition (Sousa et al.,
2014). The c.284G>T (p.Arg95Leu) mutation is located in exon 3 and also
corresponds to a distinct cytosolic non-transmembrane domain. Interest-
ingly, this mutation affects the same arginine residue (Arg-95) that is
altered in a CHO cell mutant named “29” isolated from CHO-K1 cells in
which the biochemical activating effect was first demonstrated (Hase-
gawa, Kuge, Nishijima, & Akamatsu, 1989; Kuge, Hasegawa, Saito, &
Nishijima, 1998; Ohsawa, Nishijima, & Kuge, 2004). These earlier
observations therefore strongly suggest that this mutation is also likely
to cause a gain-of function, as has been described for previously reported
mutations (Sousa et al., 2014).
The current report aims at confirming LMS as one of the
differential diagnoses of CL in the neonatal period. The two distinctive
features in the neonatal period appear to be brachydactyly and facial
dysmorphism including telecanthus and thin vermilion of the lips,
slowly evolving in a quite different dysmorphism through progressive
deformation of the skull andmandible. By contrast to some other types
of CL characterized by bone fragility, LMS displays generalized
hyperostosis (see Table 1).
Most reported patients did not survive until adulthood. Majewski,
(2000) described a prolonged survival in a 30- year-old female. This
patient had intellectual disability, marked growth failure (final height at
120 cm), hypertelorism, strabismus, large and prominent eyes, thick
lips and tongue, enlarged mandible, sparse subcutaneous fat,
prominent veins, atrophic and weak skin, massive thickening of long
tubular bones, kyphoscoliosis, limited supination and extension of the
elbow joints, brachydactyly and syndactyly.
In our patient 2, at 26 years of age,wenotably observeenlargement
of the mandible determining an elongated appearance of the face and a
wide nasal root, which appears highly set. In contrast, telecanthus,
strabismus, prominent eyes and veins were present from childhood on.
An interesting point is the regressive course of CL over the years similar
to what has been observed in most other subtypes of CL.
Although it might be difficult to draw general statements
concerning handling and follow-up of such a very rare condition
with only nine PTDSS1 mutation confirmed patients known until now,
the follow-up of such patients should comply with general recom-
mendations concerning severely to profoundly disabled individuals.
Nonetheless, special attention should be paid to their progressive
skeletal dysplasia, and particularly to disproportionate growth of the
mandible and the corresponding impairment of feeding, teeth
malocclusion and pain. Consequently periodic consultations with the
orthopedic surgeon and the dentist or the maxillofacial surgeon are
recommended.
Skeletal deformities evolve similarly to those of a lysosomal
storage disorder, progressing into dwarfismwith facial coarsening over
two decades. The marked prognathism displayed by our patient 2
resembles that observed in sclerosteosis (OMIM269500), vanBuchem
disease (OMIM 239100), or craniodiaphyseal dysplasia (OMIM
122860), the most severe and lethal form of craniotubular dysplasia,
which are all caused by SOST deficiency (Kim et al., 2011). Although no
functional link between SOST and PTDSS1 has yet been established,
the phenotypic overlap suggests activation of Wnt signaling pathway,
which normally promotes bone formation, and underlies high bone
mass disorders (MacFarlane et al., 2017).
In conclusion, we report here three patients with LMS and
heterozygous mutations in PTDSS1. We describe an adult phenotype
and two novel PTDSS1 mutations. We suggest that LMS should be
considered in the differential diagnosis of a newborn with CL.
Brachydactyly and facial dysmorphism should guide the correct
diagnosis at this period. While the CL improves with age, in contrast
to other CL-associated syndromes, LMS evolves to a severe skeletal
dysplasia with major growth failure alongside with severe intellectual
disability. Therefore this syndrome can be easily distinguishable from
other forms of CL at later stages.
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